These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36640860)

  • 41. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
    Greene SJ; Fonarow GC; DeVore AD; Sharma PP; Vaduganathan M; Albert NM; Duffy CI; Hill CL; McCague K; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Butler J
    J Am Coll Cardiol; 2019 May; 73(19):2365-2383. PubMed ID: 30844480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
    Bánfi-Bacsárdi F; Muk B; Pilecky D; Duray GZ; Kiss RG; Nyolczas N
    Cardiology; 2023; 148(1):27-37. PubMed ID: 36470212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.
    Oyanguren J; García-Garrido L; Nebot Margalef M; Lekuona I; Comin-Colet J; Manito N; Roure J; Ruiz Rodriguez P; Enjuanes C; Latorre P; Torcal Laguna J; García-Gutiérrez S;
    ESC Heart Fail; 2017 Nov; 4(4):507-519. PubMed ID: 29154427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study.
    Greene SJ; Lautsch D; Gaggin HK; Djatche LM; Zhou M; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    Am Heart J; 2022 Sep; 251():127-136. PubMed ID: 35640728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mineralocorticoid Receptor Antagonist Utilization in a Nationally Representative Heart Failure With Reduced Ejection Fraction Outpatient Population: A Cross-Sectional Study.
    Joyner KR; Soric MM; Boyle JA; Moorman JM; Fredrickson ME; Turosky JZ; Kleven CL
    Am J Ther; 2020; 27(2):e165-e176. PubMed ID: 30074530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of Worsening Heart Failure in a Population-based Cohort from Alberta, Canada: Evaluating Eligibility for Treatment With Vericiguat.
    Sepehrvand N; Islam S; Dover DC; Kaul P; McAlister FA; Armstrong PW; Ezekowitz JA
    J Card Fail; 2022 Aug; 28(8):1298-1308. PubMed ID: 35589087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining Care Planning Efficiency and Clinical Decision Support Adoption in a System Tailoring to Nurses' Graph Literacy: National, Web-Based Randomized Controlled Trial.
    Yao Y; Dunn Lopez K; Bjarnadottir RI; Macieira TGR; Dos Santos FC; Madandola OO; Cho H; Priola KJB; Wolf J; Wilkie DJ; Keenan G
    J Med Internet Res; 2023 Aug; 25():e45043. PubMed ID: 37566456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care.
    Nemis-White JM; Hamilton LM; Shaw S; MacKillop JH; Parkash R; Choudhri SH; Ciaccia A; Xie F; Thabane L; Cox JL;
    Trials; 2021 Aug; 22(1):531. PubMed ID: 34380542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. De-Implementing Opioids for Dental Extractions (DIODE): a multi-clinic, cluster-randomized trial of clinical decision support strategies in dentistry.
    Gryczynski J; Mitchell SG; Asche SE; Truitt AR; Worley DC; Rindal DB
    Implement Sci; 2023 Feb; 18(1):5. PubMed ID: 36765414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical decision support tool to screen health records for contraindications to stroke thrombolysis-a pilot study.
    Sun MC; Chan JA
    BMC Med Inform Decis Mak; 2015 Dec; 15():105. PubMed ID: 26667663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Decision Support Requirements for Ventricular Tachycardia Diagnosis Within the Frameworks of Knowledge and Practice: Survey Study.
    Hu Z; Wang M; Zheng S; Xu X; Zhang Z; Ge Q; Li J; Yao Y
    JMIR Hum Factors; 2024 Mar; 11():e55802. PubMed ID: 38530337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
    Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; Fonarow GC; McMurray JJV; Solomon SD
    Lancet; 2020 Jul; 396(10244):121-128. PubMed ID: 32446323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
    Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
    Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A CKD Clinical Decision Support System: A Cluster Randomized Clinical Trial in Primary Care Clinics.
    Sperl-Hillen J; Crain AL; Wetmore JB; Chumba LN; O'Connor PJ
    Kidney Med; 2024 Mar; 6(3):100777. PubMed ID: 38435072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.
    Serenelli M; Jackson A; Dewan P; Jhund PS; Petrie MC; Rossignol P; Campo G; Pitt B; Zannad F; Ferreira JP; McMurray JJV
    JACC Heart Fail; 2020 Mar; 8(3):188-198. PubMed ID: 31926854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary care clinicians' opinions before and after implementation of cancer screening and prevention clinical decision support in a clinic cluster-randomized control trial: a survey research study.
    Harry ML; Chrenka EA; Freitag LA; Saman DM; Allen CI; Asche SE; Truitt AR; Ekstrom HL; O'Connor PJ; Sperl-Hillen JAM; Ziegenfuss JY; Elliott TE
    BMC Health Serv Res; 2022 Jan; 22(1):38. PubMed ID: 34991570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
    Vaduganathan M; Greene SJ; Zhang S; Solomon N; Chiswell K; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Mcdermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Fonarow GC
    J Card Fail; 2022 Apr; 28(4):554-563. PubMed ID: 34785402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD).
    Fox CH; Vest BM; Kahn LS; Dickinson LM; Fang H; Pace W; Kimminau K; Vassalotti J; Loskutova N; Peterson K
    Implement Sci; 2013 Aug; 8():88. PubMed ID: 23927603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.